IRS1 and Alzheimer disease: Since these two modifications may compete for the same or adjacent sites, reduced O‐GlcNAcylation may lift the inhibition on phosphorylation, thereby promoting IRS‐1 phosphorylation, insulin resistance, and further AD development [168].